FRANKFURT, Germany–(BusINESS WIRE)–Merz Therapeutics, onye ndu na ngalaba nke neurotoxins na azụmaahịa n'okpuru Merz Group, yana Teijin Pharma Limited, bụ isi ụlọ ọrụ nke azụmaahịa ahụike Teijin Group, jikọtara ọnụ na-ekwupụta taa na Teijin Pharmaceuticals emeriela mgbakwunye. ngwa...
GỤKWUO